Paradoxical normalization in childhood epilepsy

N Amir1, V Gross-Tsur

  • 1Florence and Martin Miller EEG Diagnostic Unit, Shaare Zedek Medical Center, Jerusalem, Israel.

Epilepsia
|September 1, 1994
PubMed

Insights

Five children with refractory epilepsy experienced paradoxical normalization (PN), a rare phenomenon of seizure cessation and EEG improvement, following changes in anti-epileptic drug (AED) regimens. This study highlights PN in young children, presenting with psychiatric symptoms like psychosis and autistic withdrawal.

Area of Science:

  • Pediatric Neurology
  • Child Psychiatry
  • Neuropharmacology

Background:

  • Refractory epilepsy in children presents significant treatment challenges.
  • Paradoxical normalization (PN), characterized by seizure cessation and EEG improvement, is typically observed in adolescents and adults after prolonged poorly controlled seizures.
  • The underlying mechanisms of PN, particularly in pediatric populations, remain incompletely understood.

Purpose of the Study:

  • To report the occurrence of paradoxical normalization (PN) in young children with refractory epilepsy.
  • To describe the clinical presentation and latency of PN in pediatric cases.
  • To explore potential contributing factors, including anti-epileptic drug (AED) regimen changes.

Main Methods:

  • Case series reporting on five children aged 2.5 to 9 years with refractory epilepsy.
  • Observation of clinical and electroencephalographic (EEG) changes following modifications to anti-epileptic drug (AED) regimens.
  • Documentation of psychiatric and behavioral manifestations associated with seizure cessation.

Main Results:

  • Five children developed paradoxical normalization (PN) after AED regimen changes.
  • Latency between first seizure and psychosis ranged from 1.9 to 7.0 years.
  • Behavioral manifestations included schizophrenialike psychosis, autistic withdrawal, and organic mental syndrome.

Conclusions:

  • Paradoxical normalization (PN) can occur in young children with refractory epilepsy, challenging previous observations limited to older age groups.
  • Changes in anti-epileptic drug (AED) regimens may precipitate PN in susceptible pediatric patients.
  • Drug-induced alterations in neurotransmitter systems are hypothesized as a potential mechanism for PN in this pediatric cohort.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.